| NCT03553563 |
A Study of Esomeplazole (D961H) in Japanese Paediatric Patients With Reflux Esophagitis, Gastric Ulcer or Duodenal Ulcer |
https://ClinicalTrials.gov/show/NCT03553563 |
Recruiting |
AstraZeneca |
2023-01-04 |
| NCT03259191 |
Anti-reflux Mucosectomy (ARMS) is a Useful Therapy for Refractory Gastroesophageal Reflux Disease (RGERD) |
https://ClinicalTrials.gov/show/NCT03259191 |
Recruiting |
Zhongda Hospital |
2017-11-20 |
| NCT03184324 |
Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 2, Therapeutic Exploratory Study) |
https://ClinicalTrials.gov/show/NCT03184324 |
Completed |
Daewoong Pharmaceutical Co. LTD. |
2018-04-18 |
| NCT03130543 |
A Trial of Thickened Feeds to Treat Gastroesophageal Reflux in Children Admitted After Choking Spell |
https://ClinicalTrials.gov/show/NCT03130543 |
Recruiting |
Boston Children’s Hospital |
2022-03-06 |
| NCT03116841 |
Vonoprazan Study of Investigating the Effect on Sleep Disturbance Associated With Reflux Esophagitis- Exploratory Evaluation |
https://ClinicalTrials.gov/show/NCT03116841 |
Completed |
Takeda |
2017-12-20 |
| NCT02907632 |
Methoclopramide for Gastroesophageal Reflux in Premature Infants |
https://ClinicalTrials.gov/show/NCT02907632 |
Recruiting |
Kangaroo Foundation |
2019-01-31 |
| NCT02890979 |
Swallowable Sponge Cell Sampling Device and Next Generation Sequencing in Detecting Esophageal Cancer in Patients With Low or High Grade Dysplasia, Barrett Esophagus, or Gastroesophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT02890979 |
Active, not recruiting |
OHSU Knight Cancer Institute |
2020-12-31 |
| NCT02860624 |
Ilaprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Chinese Patients |
https://ClinicalTrials.gov/show/NCT02860624 |
Completed |
Livzon Pharmaceutical Group Inc. |
2013-04-30 |
| NCT02755753 |
A Study to Evaluate REbamiPide as an Adjuvant Regimen to Heal erosIve Reflux Esophagitis |
https://ClinicalTrials.gov/show/NCT02755753 |
Completed |
Severance Hospital |
2016-01-31 |
| NCT02706938 |
Impact of Head of Bed Elevation in Symptoms of Patients With Gastroesophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT02706938 |
Completed |
Universidad Nacional de Colombia |
2017-11-15 |
| NCT02637557 |
A Trial of IW-3718 for 8 Weeks in Patients With Symptomatic Gastroesophageal Reflux Disease (GERD) |
https://ClinicalTrials.gov/show/NCT02637557 |
Completed |
Ironwood Pharmaceuticals, Inc. |
2017-04-26 |
| NCT02620241 |
Influence of Intrapulmonary Percussive Ventilation (IPV) on Gastro-oesophageal Reflux (GOR). |
https://ClinicalTrials.gov/show/NCT02620241 |
Completed |
Vrije Universiteit Brussel |
2017-10-31 |
| NCT03388047 |
Feasibility of Multi-Spectral Endoscopic Imaging for Detection of Early Neoplasia in Barrett’s Oesophagus |
https://ClinicalTrials.gov/show/NCT03388047 |
Recruiting |
University of Cambridge |
2020-12-31 |
| NCT02513784 |
Trial to Assess the Effects of an Antimicrobial Mouthwash on the Esophageal Microbiome |
https://ClinicalTrials.gov/show/NCT02513784 |
Completed |
Columbia University |
2017-12-31 |
| NCT02463643 |
To Evaluate Efficacy and Safety of Z-215 in Erosive Esophagitis |
https://ClinicalTrials.gov/show/NCT02463643 |
Completed |
Zeria Pharmaceutical |
2016-10-31 |
| NCT02457429 |
A Validation Study of the Dx-pH Probe in Children for the Detection of Extra-oesophageal Reflux |
https://ClinicalTrials.gov/show/NCT02457429 |
Completed |
Manchester University NHS Foundation Trust |
2017-04-28 |
| NCT02429830 |
A Study of Reflux Management With the LINX® System for Gastroesophageal Reflux Disease After Laparoscopic Sleeve Gastrectomy |
https://ClinicalTrials.gov/show/NCT02429830 |
Active, not recruiting |
Torax Medical Incorporated |
2021-12-31 |
| NCT02351960 |
Dexlansoprazole in Asian Participants With Gastroesophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT02351960 |
Completed |
Takeda |
2016-06-22 |
| NCT02153398 |
A Phase I/III Study of D961H 10 mg and 20 mg in Japanese Paediatric Patients With Gastrointestinal Acid Related Diseases |
https://ClinicalTrials.gov/show/NCT02153398 |
Completed |
AstraZeneca |
2016-04-30 |
| NCT02135107 |
A Double-blind Comparative Study of the Efficacy and Safety of E3810 10mg Once and Twice Daily in Maintenance Therapy for PPI Resistant Gastroesophageal Reflux Disease Patients |
https://ClinicalTrials.gov/show/NCT02135107 |
Completed |
Eisai Inc. |
2016-05-31 |
| NCT02030925 |
Ph2a Study to Evaluate IW-3718 in Patients With Gastroesophageal Reflux Not Completely Responsive to Proton Pump Inhibitors |
https://ClinicalTrials.gov/show/NCT02030925 |
Completed |
Ironwood Pharmaceuticals, Inc. |
2014-12-31 |
| NCT03346174 |
Influence of Airway Clearance Techniques on GOR in Infants |
https://ClinicalTrials.gov/show/NCT03346174 |
Recruiting |
Vrije Universiteit Brussel |
2021-01-01 |
| NCT01964131 |
BE Study Between a Capsule and a Sachet Formulation of D961H by Pharmacodynamics in Japanese Healthy Male Subjects |
https://ClinicalTrials.gov/show/NCT01964131 |
Completed |
AstraZeneca |
2013-12-31 |
| NCT01946971 |
Lansoprazole in Preterm Infants With Gastroesophageal Reflux (GER) |
https://ClinicalTrials.gov/show/NCT01946971 |
Completed |
Seoul National University Hospital |
2014-07-31 |
| NCT01888549 |
Efficacy of Proton Pump Inhibitor for Chronic Cough Caused by Gastroesophageal Reflux; Double-blind, Placebo-controlled, Randomized Clinical Trial |
https://ClinicalTrials.gov/show/NCT01888549 |
Completed |
Yonsei University |
2016-02-29 |
| NCT01882088 |
Phase IV Study of the Impact of Dietary Fibers on Symptoms and Esophageal Motility in Patients With Non-erosive GERD |
https://ClinicalTrials.gov/show/NCT01882088 |
Completed |
Russian Academy of Medical Sciences |
2016-09-30 |
| NCT01878526 |
Gastroesophageal Reflux Treatment in Scleroderma |
https://ClinicalTrials.gov/show/NCT01878526 |
Completed |
Khon Kaen University |
2015-08-31 |
| NCT01860482 |
The Study to Evaluate Efficacy and Safety of Newrabell® Tab.(Rabeprazole Sodium) 10mg b.i.d in Refractory GERD |
https://ClinicalTrials.gov/show/NCT01860482 |
Completed |
Chong Kun Dang Pharmaceutical |
2015-05-31 |
| NCT01818570 |
A Study of Local Effect and Safety of a Single PPC-5650 Dose on Reflux Pain During Pain Stimulation in the Esophagus |
https://ClinicalTrials.gov/show/NCT01818570 |
Completed |
Aalborg University Hospital |
2014-01-31 |
| NCT01733810 |
The Role of HIF-2a in the Pathogenesis of Reflux Esophagitis |
https://ClinicalTrials.gov/show/NCT01733810 |
Completed |
Dallas VA Medical Center |
2015-07-31 |
| NCT01669811 |
Compare D961H 20 mg Bid and 20 mg qd in Patients With Refractory Reflux Esophagitis (Inflammation of Lower Esophagus) |
https://ClinicalTrials.gov/show/NCT01669811 |
Completed |
AstraZeneca |
2014-05-31 |
| NCT01642602 |
Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules in Treating Symptomatic Non-Erosive Gastroesophageal Reflux Disease in Adolescents |
https://ClinicalTrials.gov/show/NCT01642602 |
Completed |
Takeda |
2014-01-31 |
| NCT01599858 |
Effect of Repeated Doses of YF476, Omeprazole and Placebo on Stomach Acidity in Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT01599858 |
Completed |
Trio Medicines Ltd. |
1996-10-31 |
| NCT01597674 |
Effect of 5, 10 or 25 mg of YF476 Daily for 14 Days on Stomach Acidity in Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT01597674 |
Completed |
Trio Medicines Ltd. |
1997-06-30 |
| NCT01578642 |
Feasibility Study for Evaluating the Effect of Electrical Stimulation on Lower Esophageal Sphincter Pressure and Esophageal Acid Exposure in Patients With Gastroesophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT01578642 |
Completed |
EndoStim Inc. |
2013-05-31 |
| NCT01570842 |
Anthropometry in Gastroesophageal Reflux Disease and Esophageal Injury |
https://ClinicalTrials.gov/show/NCT01570842 |
Completed |
Mayo Clinic |
2012-11-30 |
| NCT01538849 |
Study to Investigate the Safety, Tolerability and Efficacy of YH4808 in Patients With Reflux Esophagitis |
https://ClinicalTrials.gov/show/NCT01538849 |
Completed |
Yuhan Corporation |
2013-11-30 |
| NCT01538797 |
Effect of Single Doses of YF476 on Stomach Acidity Compared With Ranitidine and Placebo in Fasted and Fed States |
https://ClinicalTrials.gov/show/NCT01538797 |
Completed |
Trio Medicines Ltd. |
1996-08-31 |
| NCT01538784 |
Safety, Tolerability and Pharmacokinetics of Single Rising Doses of YF476, a Gastrin Antagonist, in Healthy Men |
https://ClinicalTrials.gov/show/NCT01538784 |
Completed |
Trio Medicines Ltd. |
1996-06-30 |
| NCT01493089 |
Phase III Study Comparing Zegerid® With Losec® for the Relief of Heartburn Associated With Gastroesophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT01493089 |
Completed |
Norgine |
2011-10-31 |
| NCT01474369 |
Efficacy of TAK-438 Compared to Placebo in the Treatment of Non-Erosive Gastroesophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT01474369 |
Completed |
Takeda |
2013-02-28 |
| NCT01472939 |
Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD) |
https://ClinicalTrials.gov/show/NCT01472939 |
Completed |
Shire |
2013-05-31 |
| NCT01400945 |
Efficacy Study of AGSPT201 Tablet to Treat Gastroesophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT01400945 |
Completed |
Ahn-Gook Pharmaceuticals Co.,Ltd |
2011-08-31 |
| NCT01397084 |
To Assess the Efficacy of Esomeprazole 20mg Once Daily in Subjects Who Still Had Heartburn After Receiving Rabeprazole |
https://ClinicalTrials.gov/show/NCT01397084 |
Completed |
AstraZeneca |
2012-01-31 |
| NCT01381991 |
The Efficacy of i-Scan for Detecting Reflux Esophagitis |
https://ClinicalTrials.gov/show/NCT01381991 |
Completed |
Konkuk University Hospital |
2010-11-30 |
| NCT01324986 |
A Study on the Effectiveness of Laparoscopic Fundoplication on Extraesophageal Manifestations of Gastroesophageal Reflux Disease (GERD) |
https://ClinicalTrials.gov/show/NCT01324986 |
Completed |
General Public Hospital Zell am See |
NA |
| NCT01324791 |
Laparoscopic Antireflux Surgery Versus Endoscopic Full-thickness Gastroplication for Gastroesophageal Reflux Disease (GERD) |
https://ClinicalTrials.gov/show/NCT01324791 |
Completed |
General Public Hospital Zell am See |
NA |
| NCT04255693 |
Real-life Study of Changes of Gastroesophageal Reflux Disease Manifestations Due to Behavioural and Diet Adherence |
https://ClinicalTrials.gov/show/NCT04255693 |
Recruiting |
Federal State Budgetary Scientific Institution "Federal Research Centre of Nutrition, Biotechnology |
2023-12-31 |
| NCT04202692 |
Effect of a Combination Oral Formulation of Hyaluronic Acid, Chondroitin Sulphate and Magnesium Trisilicate in Patients With Gastro-Esophageal Reflux Disease Not Fully Satisfied With Their Treatment |
https://ClinicalTrials.gov/show/NCT04202692 |
Recruiting |
SOFAR S.p.A. |
2020-12-31 |
| NCT04036942 |
Antireflux Ablation Therapy (ARAT) Vs Antireflux Mucosectomy (ARMS) In The Management Of Gastroesophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT04036942 |
Recruiting |
Coordinación de Investigación en Salud, Mexico |
2019-11-01 |
| NCT03883074 |
Effect of a Combination of Hyaluronic Acid, Chondroitin Sulphate and Magnesium Trisilicate on Subjects With GastroEsophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT03883074 |
Recruiting |
SOFAR S.p.A. |
2020-10-31 |
| NCT03788109 |
Relationship Between Gastric Accommodation, TLESRs and Reflux in HV and in GERD With or Without Overlapping Dyspepsia |
https://ClinicalTrials.gov/show/NCT03788109 |
Completed |
Universitaire Ziekenhuizen Leuven |
2018-06-15 |
| NCT03634449 |
Risks of Gastroesophageal Reflux in the Endotracheal Intubation or the I-gel |
https://ClinicalTrials.gov/show/NCT03634449 |
Recruiting |
National Taiwan University Hospital |
2019-10-13 |
| NCT03619811 |
Precision Approach to PPI Therapy in Gastroesophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT03619811 |
Recruiting |
University of California, San Diego |
2020-07-31 |
| NCT03561883 |
Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors |
https://ClinicalTrials.gov/show/NCT03561883 |
Recruiting |
Ironwood Pharmaceuticals, Inc. |
2021-06-30 |
| NCT03561233 |
Prevalence and Predictors of Proton Pump Inhibitor Partial Response in Gastroesophageal Reflux Disease in Systemic Sclerosis |
https://ClinicalTrials.gov/show/NCT03561233 |
Completed |
Khon Kaen University |
2018-05-31 |
| NCT03516188 |
Efficacy of Gaviscon-Advance® in Suppressing Post-supper Acid-pocket and Night-time Acid-reflux in Obese Participants |
https://ClinicalTrials.gov/show/NCT03516188 |
Completed |
Universiti Sains Malaysia |
2017-06-30 |
| NCT03497494 |
the Related Factors of Bariatric Surgery on Gastroesophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT03497494 |
Active, not recruiting |
First Affiliated Hospital of Jinan University |
2019-12-30 |
| NCT03467438 |
Efficacy of Zinc L-carnosine in Maintaining Remission of Gastroesophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT03467438 |
Recruiting |
IRCCS Policlinico S. Matteo |
2020-04-01 |
| NCT03425097 |
Fexofenadine Use in Gastroesophageal Reflux Symptoms |
https://ClinicalTrials.gov/show/NCT03425097 |
Recruiting |
Stanford University |
2020-03-31 |
| NCT01260935 |
Comparison of Laparoscopic Hill and Laparoscopic Nissen Anti-Reflux Procedures |
https://ClinicalTrials.gov/show/NCT01260935 |
Completed |
Swedish Medical Center |
2010-11-30 |
| NCT01161602 |
A Study to Evaluate the Safety, Tolerability and Pharmacodynamics of Pumosetrag in Patients With Gastroesophageal Reflux Disease (GERD) |
https://ClinicalTrials.gov/show/NCT01161602 |
Completed |
Edusa Pharmaceuticals, Inc. |
NA |
| NCT01118585 |
Transoral Incisionless Fundoplication (TIF) Registry Study for Treatment of Gastroesophageal Reflux Disease (GERD) |
https://ClinicalTrials.gov/show/NCT01118585 |
Completed |
EndoGastric Solutions |
2015-06-30 |
| NCT01110811 |
Transoral Incisionless Fundoplication (TIF) Versus Sham for Treatment of Gastroesophageal Reflux Disease (GERD) |
https://ClinicalTrials.gov/show/NCT01110811 |
Completed |
EndoGastric Solutions |
2015-09-30 |
| NCT01045096 |
Study to Evaluate the Pharmacokinetics and Safety of Dexlansoprazole in Pediatric Subjects With Symptomatic Gastroesophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT01045096 |
Completed |
Takeda |
2011-02-28 |
| NCT01043185 |
A Study to Estimate Effect of 4 Different Doses of AZD3355 on Reflux Episodes, Which Patients With Gastroesophageal Reflux Disease (GERD) May Experience |
https://ClinicalTrials.gov/show/NCT01043185 |
Completed |
AstraZeneca |
2010-05-31 |
| NCT01039558 |
The Effect of Lansoprazole in Combination With Ecabet Sodium for Gastroesophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT01039558 |
Completed |
Seoul National University Hospital |
2011-03-31 |
| NCT01008696 |
An Efficacy Study to Compare the Treatment Effects of Rabeprazole and Lansoprazole Depending on the Genotyping of CYP2C19 in Treating Reflux Esophagitis |
https://ClinicalTrials.gov/show/NCT01008696 |
Completed |
Janssen Korea, Ltd., Korea |
2008-08-31 |
| NCT00998244 |
Study to Evaluate the Effect of a Very Low Carbohydrate Diet on Gastroesophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT00998244 |
Completed |
University of North Carolina, Chapel Hill |
2011-12-31 |
| NCT00978016 |
A Study to Evaluate the Efficacy and Safety of Arbaclofen Placarbil (XP19986) as Adjunctive Therapy in Subjects With Gastroesophageal Reflux Disease (GERD) |
https://ClinicalTrials.gov/show/NCT00978016 |
Completed |
Indivior Inc. |
2010-12-31 |
| NCT00926276 |
The Role of Anti-Reflux Surgery for Gastroesophageal Reflux Disease in Premature Infants With Bronchopulmonary Dysplasia |
https://ClinicalTrials.gov/show/NCT00926276 |
Completed |
The University of Texas Health Science Center, Houston |
2013-05-31 |
| NCT00911534 |
Comparing the Efficacy, Safety, and Tolerability of Rabeprazole ER 50 mg With Placebo in Subjects With Symptomatic Gastroesophageal Reflux Disease (sGERD) |
https://ClinicalTrials.gov/show/NCT00911534 |
Completed |
Eisai Inc. |
2009-07-31 |
| NCT00872755 |
Nissen and Gastroplasty in Gastroesophageal Reflux Disease (GERD) |
https://ClinicalTrials.gov/show/NCT00872755 |
Completed |
G. Hatzikosta General Hospital |
2008-04-30 |
| NCT00868296 |
Open Label Safety Study of Enteric-Coated Spheroid Suspension in Infants Aged Less Than 12 Months With Presumed Gastroesophageal Reflux Disease (GERD) |
https://ClinicalTrials.gov/show/NCT00868296 |
Completed |
Wyeth is now a wholly owned subsidiary of Pfizer |
2008-03-31 |
| NCT00855361 |
A Pharmacokinetics, Pharmacodynamics and Safety Study of Rabeprazole in New Born Infants With Gastroesophageal Reflux Disease (GERD) |
https://ClinicalTrials.gov/show/NCT00855361 |
Completed |
Janssen Research & Development, LLC |
2011-12-31 |
| NCT00847808 |
Efficacy of Dexlansoprazole MR on Heartburn Control in Participants Previously Receiving Twice Daily Proton Pump Inhibitor Therapy |
https://ClinicalTrials.gov/show/NCT00847808 |
Completed |
Takeda |
2010-04-30 |
| NCT00847210 |
Pharmacokinetic and Safety of Dexlansoprazole in Adolescents With Gastroesophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT00847210 |
Completed |
Takeda |
2009-09-30 |
| NCT00839306 |
Rabeprazole Extended Release 50 mg Versus Ranitidine 150 mg for Maintenance of Healed Erosive Gastroesophageal Reflux Disease (GERD) |
https://ClinicalTrials.gov/show/NCT00839306 |
Completed |
Eisai Inc. |
2009-08-31 |
| NCT00838526 |
Rabeprazole Extended-Release 50 mg vs. Ranitidine 150 mg for Maintenance of Healed Erosive Gastroesophageal Reflux Disease (GERD) |
https://ClinicalTrials.gov/show/NCT00838526 |
Completed |
Eisai Inc. |
2009-07-31 |
| NCT00810485 |
ADX10059 as an add-on Therapy to Proton Pump Inhibitors (PPIs) in Patients With Gastroesophageal Reflux (GERD) |
https://ClinicalTrials.gov/show/NCT00810485 |
Completed |
Addex Pharma S.A. |
2009-12-31 |
| NCT03561090 |
A Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors |
https://ClinicalTrials.gov/show/NCT03561090 |
Recruiting |
Ironwood Pharmaceuticals, Inc. |
2021-06-30 |
| NCT03299985 |
Diaphragmatic Myofascial Release in Gastroesophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT03299985 |
Completed |
Cardenal Herrera University |
2018-03-15 |
| NCT02954848 |
Phase 3 Study of TAK-438 10 mg in the Treatment of Non-Erosive Gastroesophageal Reflux Disease (NERD) |
https://ClinicalTrials.gov/show/NCT02954848 |
Completed |
Takeda |
2018-02-25 |
| NCT00787891 |
A Study of the Safety and Effectiveness of Rabeprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Pediatric Patients |
https://ClinicalTrials.gov/show/NCT00787891 |
Completed |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
2011-01-31 |
| NCT00786695 |
Study Using Esomeprazole as a Diagnostic Test for GERD in Patients With NCCP |
https://ClinicalTrials.gov/show/NCT00786695 |
Completed |
National University Hospital, Singapore |
2009-12-31 |
| NCT00770913 |
Double-blind Comparative Study of E3810 Tablets (10 or 20 mg b.i.d.) to Evaluate Efficacy and Safety in Patients With Refractory Reflux Esophagitis |
https://ClinicalTrials.gov/show/NCT00770913 |
Completed |
Eisai Inc. |
2009-11-30 |
| NCT02124863 |
Influence of IPV on GOR in Infants From 0 to 12 Months. |
https://ClinicalTrials.gov/show/NCT02124863 |
Completed |
Vrije Universiteit Brussel |
2015-01-31 |
| NCT00747526 |
A Study of Single and Multiple Doses of Rabeprazole in Pediatric Patients With Gastroesophageal Reflux Disease (GERD) 1 to 11 Months Old, Inclusive |
https://ClinicalTrials.gov/show/NCT00747526 |
Completed |
Janssen Research & Development, LLC |
2012-02-29 |
| NCT00744419 |
Intravenous (IV) Pantoprazole for Gastroesophageal Reflux Disease (GERD) in Neonates and Infants |
https://ClinicalTrials.gov/show/NCT00744419 |
Completed |
University of Louisville |
2012-04-30 |
| NCT00734747 |
Safety and Efficacy the Medigus SRS Endoscopic Stapling System in Gastroesophageal Reflux Disease (GERD) |
https://ClinicalTrials.gov/show/NCT00734747 |
Completed |
Medigus Ltd |
2011-05-31 |
| NCT00734097 |
A Study of Nexium (Esomeprazole) 40 mg Once Daily in Subjects With Symptoms of Gastroesophageal Reflux Disease (GORD) After Treatment With a Full Dose of Proton Pump Inhibitor (PPI) |
https://ClinicalTrials.gov/show/NCT00734097 |
Completed |
AstraZeneca |
2008-10-31 |
| NCT00729339 |
Role of Mosapride in Patients With Gastroesophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT00729339 |
Completed |
Lotung Poh-Ai Hospital |
2009-04-30 |
| NCT00728481 |
The Role Of Gastroesophageal Reflux Disease (GERD) in Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT00728481 |
Completed |
Mayo Clinic |
2010-12-31 |
| NCT00693225 |
Impact of Timing on the Efficacy of Zegerid 40 mg in Healing Reflux Esophagitis: A Pilot Study |
https://ClinicalTrials.gov/show/NCT00693225 |
Completed |
Mayo Clinic |
2010-12-31 |
| NCT00660660 |
Local Phase IV, Gastroesophageal Reflux Disease (GERD) Sleep Study US |
https://ClinicalTrials.gov/show/NCT00660660 |
Completed |
AstraZeneca |
2008-07-31 |
| NCT00658775 |
Rabeprazole Extended-Release, 50 mg, Versus Esomeprazole, 40 mg, for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD) |
https://ClinicalTrials.gov/show/NCT00658775 |
Completed |
Eisai Inc. |
2009-09-30 |
| NCT00658632 |
Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD) |
https://ClinicalTrials.gov/show/NCT00658632 |
Completed |
Eisai Inc. |
2009-04-30 |
| NCT00658528 |
Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD) |
https://ClinicalTrials.gov/show/NCT00658528 |
Completed |
Eisai Inc. |
2009-09-30 |
| NCT00634114 |
Reflux Esophagitis Phase III Study (Maintenance Treatment) |
https://ClinicalTrials.gov/show/NCT00634114 |
Completed |
AstraZeneca |
NA |
| NCT00633932 |
Reflux Esophagitis Phase III Study (Initial Treatment) |
https://ClinicalTrials.gov/show/NCT00633932 |
Completed |
AstraZeneca |
NA |
| NCT00628342 |
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment With Esomeprazole 20 mg qd and 40 mg qd to Placebo qd in Patients With Heartburn and Sleep Disturbances Associated With Gastroesophageal Reflux Disease (GERD) |
https://ClinicalTrials.gov/show/NCT00628342 |
Completed |
AstraZeneca |
2003-08-31 |
| NCT00627016 |
A Study of Dexlansoprazole Modified Release Formulation to Treat Night Heartburn |
https://ClinicalTrials.gov/show/NCT00627016 |
Completed |
Takeda |
2009-03-31 |
| NCT00626535 |
A Multicenter, Randomized, Double-Blind Parallel-Group, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment With Esomeprazole 20 mg Once Daily to Placebo qd for the Resolution of Upper Abdominal Pain in Patients With Symptomatic Gastroesophageal Reflux Disease (sGERD) |
https://ClinicalTrials.gov/show/NCT00626535 |
Completed |
AstraZeneca |
2004-02-29 |
| NCT00626262 |
Open, Randomized, Two Way Crossover Study Comparing the Effect of Esomeprazole Adminstered Orally and iv |
https://ClinicalTrials.gov/show/NCT00626262 |
Completed |
AstraZeneca |
2002-10-31 |
| NCT00625495 |
Study Comparing the Effects of Esomeprazole Adminstered Orally and Intravenously on Basal and Pentrigastrin-stimulated Acid Output in Subjects With Symptoms of Gastroesophageal Reflux Disease (GERD) |
https://ClinicalTrials.gov/show/NCT00625495 |
Completed |
AstraZeneca |
2002-11-30 |
| NCT00618150 |
Patient Education in Gastroesophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT00618150 |
Completed |
Norwegian University of Science and Technology |
1999-12-31 |
| NCT00464308 |
A Study to Compare the Number of Patients With Gastro-Oesophageal Reflux Disease (GORD) Achieving Heartburn and Regurgitation Symptom Resolution After Treatment With Either Rabeprazole Sodium 20mg, Esomeprazole 20mg or Esomeprazole 40mg |
https://ClinicalTrials.gov/show/NCT00464308 |
Completed |
Janssen-Cilag Pty Ltd |
2008-05-31 |
| NCT00414856 |
Effects of AFQ056 and Baclofen on Meal-Induced Gastroesophageal Reflux |
https://ClinicalTrials.gov/show/NCT00414856 |
Completed |
Novartis |
NA |
| NCT00394472 |
Symptom Improvements in Gastroesophageal Reflux Disease (GERD) Patients |
https://ClinicalTrials.gov/show/NCT00394472 |
Completed |
AstraZeneca |
2007-06-30 |
| NCT00820079 |
ADX10059 as a Monotherapy in Patients With Gastroesophageal Reflux (GERD) |
https://ClinicalTrials.gov/show/NCT00820079 |
Completed |
Addex Pharma S.A. |
2009-10-31 |
| NCT00373334 |
Safety and Efficacy Study of Axid Use in Infants Suffering From Gastroesophageal Reflux Disease (GERD) |
https://ClinicalTrials.gov/show/NCT00373334 |
Completed |
Braintree Laboratories |
2008-02-29 |
| NCT00365300 |
Study Evaluating the Efficacy and Safety of Pantoprazole in Infants With Symptomatic Gastroesophageal Reflux Disease (GERD) |
https://ClinicalTrials.gov/show/NCT00365300 |
Completed |
Wyeth is now a wholly owned subsidiary of Pfizer |
2007-11-30 |
| NCT00346905 |
Endoscopic Implantation of Enteryx for the Treatment of GERD |
https://ClinicalTrials.gov/show/NCT00346905 |
Completed |
Beth Israel Deaconess Medical Center |
2008-02-29 |
| NCT00326027 |
Efficacy of Pantoprazole in Patients Older Than 18 Years Who Have Symptoms of Non-erosive Reflux or Gastroesophageal Reflux Disease (BY1023/DE-004) |
https://ClinicalTrials.gov/show/NCT00326027 |
Completed |
Nycomed |
2007-07-31 |
| NCT00325676 |
Comparison of the Classical Healing Concept With the Complete Remission Concept After Treatment With Pantoprazole in Adult Patients With Erosive GERD (Gastroesophageal Reflux Disease) (BY1023/M3-342) |
https://ClinicalTrials.gov/show/NCT00325676 |
Completed |
Takeda |
NA |
| NCT00324974 |
The Use of Lansoprazole to Treat Infants With Symptoms of Gastroesophageal Reflux |
https://ClinicalTrials.gov/show/NCT00324974 |
Completed |
Takeda |
2007-05-31 |
| NCT00321984 |
Safety and Efficacy of Dexlansoprazole Modified Release Formulation to Treat Gastroesophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT00321984 |
Completed |
Takeda |
2006-12-31 |
| NCT00321737 |
Efficacy and Safety of Dexlansoprazole MR Compared to Placebo on Maintaining Healing in Subjects With Healed Erosive Esophagitis |
https://ClinicalTrials.gov/show/NCT00321737 |
Completed |
Takeda |
2007-05-31 |
| NCT00312806 |
Effect of Pantoprazole on the Symptoms of Acid Reflux Disease in Adult Patients (BY1023/M3-341) |
https://ClinicalTrials.gov/show/NCT00312806 |
Completed |
Takeda |
2007-03-31 |
| NCT00307944 |
Study of Pantoprazole for Sleepiness Associated With Acid Reflux and Sleep Apnea |
https://ClinicalTrials.gov/show/NCT00307944 |
Completed |
University of Cincinnati |
NA |
| NCT00300755 |
Study Evaluating Pantoprazole in Children With Gastroesophageal Reflux Disease (GERD) |
https://ClinicalTrials.gov/show/NCT00300755 |
Completed |
Wyeth is now a wholly owned subsidiary of Pfizer |
2008-04-30 |
| NCT00261339 |
Determination of a Questionnaire After Treatment With Pantoprazole at Full Dose and Half Dose in Adult Patients With Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/UK-506) |
https://ClinicalTrials.gov/show/NCT00261339 |
Completed |
Takeda |
NA |
| NCT00255164 |
Efficacy and Safety of Dexlansoprazole MR on Maintaining Healing in Subjects With Healed Erosive Esophagitis |
https://ClinicalTrials.gov/show/NCT00255164 |
Completed |
Takeda |
2006-11-30 |
| NCT00255151 |
Comparison of Dexlansoprazole MR to Placebo on the Ability to Maintain Healing in Subjects With Healed Erosive Esophagitis |
https://ClinicalTrials.gov/show/NCT00255151 |
Completed |
Takeda |
2006-11-30 |
| NCT00251927 |
Esomeprazole (NEXIUM) vs. Surgery |
https://ClinicalTrials.gov/show/NCT00251927 |
Completed |
AstraZeneca |
2009-04-30 |
| NCT00251758 |
Safety and Efficacy of Dexlansoprazole Modified Release Formulation to Treat Heartburn |
https://ClinicalTrials.gov/show/NCT00251758 |
Completed |
Takeda |
2006-05-31 |
| NCT00251745 |
Efficacy and Safety of Dexlansoprazole Modified Release Formulation to Treat Heartburn |
https://ClinicalTrials.gov/show/NCT00251745 |
Completed |
Takeda |
2006-05-31 |
| NCT00251719 |
Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive Esophagitis |
https://ClinicalTrials.gov/show/NCT00251719 |
Completed |
Takeda |
2007-01-31 |
| NCT00251693 |
Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive Esophagitis |
https://ClinicalTrials.gov/show/NCT00251693 |
Completed |
Takeda |
2007-01-31 |
| NCT00246909 |
Determination of the Minimal Clinically Important Difference After Treatment With Pantoprazole in Patients With Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/M3-340) |
https://ClinicalTrials.gov/show/NCT00246909 |
Completed |
Takeda |
2006-11-30 |
| NCT00237367 |
A Study of Rabeprazole and Pantoprazole on Stomach Acid and Esophageal Acid Exposure in Patients With Gastroesophageal Reflux Disease (GERD) and a History of Nighttime Heartburn |
https://ClinicalTrials.gov/show/NCT00237367 |
Completed |
PriCara, Unit of Ortho-McNeil, Inc. |
NA |
| NCT00235677 |
Treatment Of Gastroesophageal Reflux Disease By Endoscopic Fundoplication, A Placebo-Controlled Study |
https://ClinicalTrials.gov/show/NCT00235677 |
Completed |
UMC Utrecht |
NA |
| NCT00229424 |
Verification Study on Lafutidine in Mild Reflux Oesophagitis - Double Blind Controlled Study With Famotidine - |
https://ClinicalTrials.gov/show/NCT00229424 |
Completed |
Taiho Pharmaceutical Co., Ltd. |
2006-10-31 |
| NCT00220818 |
A Study to Evaluate the Effect of Lansoprazole on Infants With Gastroesophageal Reflux Disease. |
https://ClinicalTrials.gov/show/NCT00220818 |
Completed |
Takeda |
2005-07-31 |
| NCT00217347 |
Evaluation of Efficiency of Esophageal Capsule Endoscopy in the Screening of Patients With Gastroesophageal Reflux Disease or Dyspepsia as Compared to Upper Endoscopy |
https://ClinicalTrials.gov/show/NCT00217347 |
Completed |
Nantes University Hospital |
NA |
| NCT00216489 |
A Study of the Safety of Rabeprazole Administered to Adults With Gastroesophageal Reflux Disease (GERD) |
https://ClinicalTrials.gov/show/NCT00216489 |
Completed |
Janssen Cilag Pharmaceutica S.A.C.I., Greece |
NA |
| NCT00206180 |
NEXIUM® in the Treatment of Moderate and Severe Erosive Esophagitis |
https://ClinicalTrials.gov/show/NCT00206180 |
Completed |
AstraZeneca |
NA |
| NCT00200642 |
Evaluation of the Efficiency of Radiofrequency in the Treatment of Gastroesophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT00200642 |
Completed |
Nantes University Hospital |
NA |
| NCT00194376 |
Evaluation of Gastroesophageal Reflux in Patients on Continuous Positive Airway Pressure Ventilation for Obstructive Sleep Apnea |
https://ClinicalTrials.gov/show/NCT00194376 |
Completed |
University of Pennsylvania |
2006-09-30 |
| NCT00174928 |
A Study to Evaluate the Effect of Lansoprazole on Hospitalized Neonates With Gastroesophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT00174928 |
Completed |
Takeda |
2005-08-31 |
| NCT00171483 |
Assessment of the Role of Tegaserod Therapy in the Management of Gastroesophageal Reflux Disease (GERD) Symptoms in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs). |
https://ClinicalTrials.gov/show/NCT00171483 |
Completed |
Novartis |
NA |
| NCT00171418 |
Assessment of the Effects of Tegaserod in the Management of Gastroesophageal Reflux Disease (GERD) in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs). |
https://ClinicalTrials.gov/show/NCT00171418 |
Completed |
Novartis |
NA |
| NCT00165672 |
A Study of E3810 With Pre- and Post-Treatment pH Monitoring in Patients With Non-Erosive Gastroesophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT00165672 |
Completed |
Eisai Inc. |
2005-10-31 |
| NCT00165646 |
A Comparative Study on the Efficacy and Safety of E3810 in Patients With Non-erosive Gastroesophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT00165646 |
Completed |
Eisai Inc. |
2005-10-31 |
| NCT00164840 |
Symptomatic Gastroesophageal Reflux Disease: Double Blind Randomized Controlled Study of On-demand Therapy Versus Maintenance Therapy |
https://ClinicalTrials.gov/show/NCT00164840 |
Completed |
Chinese University of Hong Kong |
2008-11-30 |
| NCT00163306 |
Efficacy of Pantoprazole in Patients Older Than 18 Years Who Have Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/M3-339) |
https://ClinicalTrials.gov/show/NCT00163306 |
Completed |
Takeda |
NA |
| NCT00141960 |
Famotidine in Subjects With Non-erosive Gastroesophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT00141960 |
Completed |
Astellas Pharma Inc |
NA |
| NCT00132496 |
Treatment of Gastroesophageal Reflux Disease in 12-16 Year Old Patients With Rabeprazole |
https://ClinicalTrials.gov/show/NCT00132496 |
Completed |
Eisai Inc. |
2006-05-31 |
| NCT00131248 |
Medical Treatment for Gastroesophageal Reflux Disease (GERD) in Preterm Infants |
https://ClinicalTrials.gov/show/NCT00131248 |
Completed |
The University of Texas Health Science Center, Houston |
2008-03-31 |
| NCT00057174 |
Economic Impact of Guidelines for Gastroesophageal Reflux Disease |
https://ClinicalTrials.gov/show/NCT00057174 |
Completed |
VA Office of Research and Development |
NA |